Related Experiment Videos
The effects of methylphenidate on the soft neurological signs of hyperactive children
Insights
Methylphenidate hydrochloride (Ritalin) significantly improved neurological signs in most hyperactive children. This treatment showed effectiveness beyond placebo, suggesting independent effects on behavior and motor functions.
Area of Science:
- Neurology
- Pediatrics
- Pharmacology
Background:
- Hyperactive children often exhibit abnormal neurological signs.
- Neurological abnormalities can impact a child's development and behavior.
Purpose of the Study:
- To evaluate the effect of methylphenidate hydrochloride on neurological signs in hyperactive children.
- To determine if behavioral improvements correlate with neurological sign resolution.
Main Methods:
- A 60-day treatment study involving 40 hyperactive children with pre-existing neurological abnormalities.
- Comparison with a placebo group of 20 hyperactive children.
- Assessment using neurological examinations and Conners' Abbreviated Teacher Rating Scale.
Main Results:
- 72.5% of children treated with methylphenidate showed improvement or resolution of neurological signs.
- Placebo treatment did not significantly alter neurological status.
- Behavioral improvement did not consistently align with the resolution of neurological signs.
Conclusions:
- Methylphenidate hydrochloride is effective in resolving neurological abnormalities in hyperactive children.
- The drug appears to affect behavioral and motor functions independently.
- Neurological assessment should be part of routine follow-up for treated hyperactive children.
Abstract:
The neurological examination of many hyperactive children reveals the presence of abnormal neurological signs. Of 40 hyperactive children who had three or more neurological abnormalities on an initial neurological evaluation, 29 (72.5%) showed marked improvement or complete resolution of the neurological signs following treatment with methylphenidate hydrochloride (Ritalin) for 60 days. The administration of placebo did not change appreciably the neurological status of 20 hyperactive children. Improvement in behavior, which was ascertained by the use of Conners' Abbreviated Teacher Rating Scale, did not always correspond with resolution of the abnormal neurological signs. This finding suggests that methylphenidate affects behavioral and motoric functions separately and independently. Repeat neurological assessment, looking for resolution of abnormal neurological signs, should be included as part of the follow-up medical examination in treated hyperactive children. Coupled with other objective and subjective test information, improvement of the neurological status provides supportive evidence of overall improvement in the hyperactive child who is receiving drug therapy.